Avinoam has cumulative experience of two decades in the pharmaceutical industry, during which he has held a number of positions in management, marketing, sales and mergers & acquisitions. Inter alia Among other positions, Avinoam served as CEO of SLE (Israel’s largest distribution company and a subsidiary of Teva), VP and CEO of Teva Israel, founder and chairman of Sanara Ventures Investment Fund (a JV of Philips and Teva). Among other executive roles with Teva, Avinoam also served as Regional Director MEA of Teva’s global operations.
CEO of Tikun Olam-Cannbit
Former member of the 19th Knesset which introduced the Prevention of Sexual Harassment Law and the Proper Representation of Women in Local Authorities Law. In 2019 she was appointed general manager of Cannbit, which embarked on an IPO that year and led the acquisition of Tikun Olam. Until 2019 she served in a variety of positions, including VP Business Development in the Danel Group, head of the Youth Division in the Ministry for Negev and Galilee Development, head of education and welfare in the Local Government Center, and other social and educational positions.
Deputy General Manager for Government Relations
leads our clinical research, data collection and database management, analysis, and product development, with the goal of reaching the highest level of cannabis products, while conducting innovative and groundbreaking collaborations in the field. Lihi is a doctoral student in epidemiology at the Clinical Research Center at Soroka Medical Center and Ben-Gurion University, under the supervision of Prof. Victor Novak and Prof. Raphael Mechoulam, the father of medical cannabis research.
Lihi Bar-Lev Schleider
Head of R&D and Founder of the research department
previously served as controller with the Malibu Israel Group, and as finance manager of various companies in Azrieli Group, and in other public companies. He served as a portfolio auditor at accounting firm Somekh Chaikin and as an economist with the Manufacturers Association and in the Coordination Bureau of Economic Organizations. Liad holds a bachelor’s degree in economics, business administration and accounting from Bar Ilan University and is a graduate of the Directors in Industry course of the Manufacturers Association.
has proven experience in creating international partnerships and in managing technological projects in the world of healthcare. Guy, a graduate of the Naval Officers Course (Major, Res.), gained a bachelor’s degree in political science and business administration in the framework of his military service, a second bachelor’s degree in plant science and biotechnology from the Hebrew University, and a master’s degree from the Department of Molecular Genetics at the Weizmann Institute of Science.
VP Business Development
Eshel has been involved in the global cannabis industry for seven years, starting out at Tikun Olam’s agricultural farm, from where he moved to California. It was there that he set up and managed projects for the industry and pioneered CO2 Extraction for botanical distillation. Long before the change in the legal structure globally and in the United States, Eshel recognized the industry’s potential and established one of the earliest large-scale CBD farms in the U.S. Eshel now leads our international business development and brings his huge knowledge into play when promoting collaborations in Europe and elsewhere in the world for medical and leisure markets.
International Business Development
Including with Israel’s Ministry of Health and with customers and suppliers. As the company’s Pharmacist and a member of its quality assurance team, she ensures that the company’s products are manufactured, stored, and transported in accordance with the applicable standards. She checks batch quality before their release for marketing and provides professional advice to all the company’s departments. Dr. Carmi, who is an experienced pharmacist and researcher, has a bachelor’s and a master’s degree from the School of Pharmacy at the Hebrew University of Jerusalem, and a doctorate from the Faculty of Medicine at Bar-Ilan University, majoring in pharmacology and pharmacogenomics. Shani draws on her experience across all stages of drug development to promote optimal medicalization.